Amplification of HER-2 in gastric carcinoma: association with Topoisomerase IIα gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab-Reference-Cited by-同舟云学术

Amplification of HER-2 in gastric carcinoma: association with Topoisomerase IIα gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab

Published:2005-02 Issue:2 Volume:16 Page:273-278
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Tanner M.,Hollmén M.,Junttila T.T.,Kapanen A.I.,Tommola S.,Soini Y.,Helin H.,Salo J.,Joensuu H.,Sihvo E.,Elenius K.,Isola J.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/16/2/273/328355/mdi064.pdf

Reference20 articles.

1. HER-2/neu (c-erb-B2) gene and protein in breast cancer;Ross;Am J Clin Pathol,1999

2. HER2 overexpression in various tumor types, focusing on its relationship to the development of invasive breast cancer;Menard;Ann Oncol,2001

3. 2 in other tumor types;Scholl;Ann Oncol,2001

4. Untangling the ErbB signaling network;Yarden;Nat Rev Mol Cell Biol,2001

5. Characterization of topoisomerase II alpha gene amplification and deletion in breast cancer;Jarvinen;Genes Chromosomes Cancer,1999

Cited by 581 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictive and prognostic biomarkers in gastrointestinal tract tumours;Pathology;2024-01

2. Bioprinted Organoids Platform with Tumor Vasculature for Implementing Precision Personalized Medicine Targeted Towards Gastric Cancer;Advanced Functional Materials;2023-12-03

3. A narrative review of the evolving landscape of the management of metastatic gastric cancer: the role of targeted therapies;Journal of Gastrointestinal Oncology;2023-12

4. Current and Emerging Role of Monoclonal Antibody-Based First-Line Treatment in Advanced Gastro-Esophageal and Gastric Cancer;Current Oncology;2023-10-20

5. p70S6K/Akt dual inhibitor DIACC3010 is efficacious in preclinical models of gastric cancer alone and in combination with trastuzumab;Scientific Reports;2023-09-25